Decision Back with Arvind Balasundaram

Decision Back brings together the brightest minds in decision science, leaders navigating high-stakes choices, and entrepreneurs building smarter ways to decide. Whether you're running a business or just navigating life, this conversation is for you. Press play and start making better decisions.

This week, Lanny sat down with Arvind Balasundaram, a pharma analytics leader with more than 30 years of experience across Regeneron, Sanofi, Johnson & Johnson, Bristol-Myers Squibb, and Pfizer. Together, they explore how pharma analytics has evolved—and how agentic AI will push data and analytics teams up the value chain from delivering insights to driving better decisions.

The conversation covers the future of AI in pharma, the changing role of analytics teams, and why the biggest opportunity lies not just in generating more insight, but in improving the quality and speed of decision-making.